Join our clinical research study evaluating whether survodutide, an injectable medication, can prevent liver complications and potentially improve liver health in patients with MASH featuring moderate to advanced liver fibrosis or cirrhosis (stages F2-F4).
Answer a few simple questions to see if you qualify for the study.
Is your fatty liver non-alcoholic?
Your information is secure and will only be used to determine study eligibility.
Taking part in this study may provide you with an opportunity to:
Have in-depth, long-term monitoring of your liver health (as well as any associated conditions such as type 2 diabetes and high blood pressure by experts in this field of medicine). This includes access to specialist medical tests that would not be part of standard care outside of a clinical study.
Receive long-term nutrition and physical activity advice to support you in adopting healthier lifestyle choices.
Gain in-depth understanding of your condition.
Be a partner in this quest to help improve understanding of MASH.
Potentially help other people with MASH in the future.
This is a clinical research study to identify new treatments for metabolic dysfunction-associated steatohepatitis (MASH), also known as nonalcoholic steatohepatitis (NASH) and Fibrosis.
This study tests survodutide, a dual-action medication that may not only improve liver health by reducing inflammation and scarring but also address underlying metabolic issues through weight loss and improved blood sugar control.
This is a long-term study, typically lasting several years. There will be different amounts of time that pass between each visit throughout the study (example: every 6 weeks). Some visits may be conducted remotely. The study team will go over the appointment schedule with you and address any questions you may have.
The study is being conducted at Access Research Institute, located at 11373 Cortez Blvd Building C, Suite 200, Brooksville, FL 34613.
Dr. Salman currently serves as program director for the Internal Medicine Residency Program at Oak Hill Hospital. He received his medical degree from Quaid-e-Azam University and his pre-medical training was at Sir Syed College. He then served for 13 years at Seton Hall University Internal Medicine Program at Saint Francis Medical Center in New Jersey where he completed his internal medicine residency and was a chief resident.
Internal Medicine
Consumer Research Council of America 2010, 2011, 2014 & 2015
Clinical Experience
"As a doctor, I see how challenging MASH can be. This study is a way for us to explore potential options that may help people feel better and live healthier lives. Every person who joins helps us move one step closer to better care in the future."
Participating in our study offers several potential advantages for patients with liver disease.
Participants may receive access to innovative treatments that are not widely available in standard clinical practice.
Our specialized team of doctors, nurses, and specialists provide comprehensive care throughout the study.
Study-related treatments, evaluations, and follow-up visits are provided at no cost to eligible participants.
By participating, you help advance medical knowledge and potentially improve future treatments for this condition.
Ready to join our clinical study? It's simple. Just follow these easy steps.
Schedule your first chat with our friendly team. We'll talk about your health and see if this study is a good fit for you.
We'll go over your health background, current care, and understand your condition better.
We'll walk you through everything about the study – the potential benefits and risks, what to expect, and answer all your questions.
Next, we'll do a quick check-up to make sure the study is right for your specific needs.
If you feel ready to move forward, you'll review and sign the informed consent form.
This important paper explains everything: what happens in the study, the timeline, and your rights as a participant.
You'll get a personalized treatment plan made just for you, along with a clear schedule for your participation.
Embark on your study journey and begin your first treatment session!
Find answers to common questions about our clinical research study.
A clinical trial is a research study that evaluates new medical treatments, interventions, or devices to determine if they're safe and effective for humans. These studies follow strict scientific standards and regulatory guidelines to protect participants' safety and rights. By participating in our clinical trial, you're helping to advance medical knowledge and potentially improve future treatments for this disease.
Have more questions about the study?
Call Our Friendly TeamFind out if your a good fit for the study. Our team will contact you within 24 hours.
Limited Enrollment Period
We can only accept a limited number of participants for this study.
No-Cost Evaluation
Your consultation and all study-related care is provided at no cost to you.
No Obligation
The consultation is informational only - you decide if the study is right for you.
Complete this quick form to see if you qualify
Answer a few simple questions to see if you qualify for the MASH study.
Is your fatty liver non-alcoholic?
Your information is secure and will only be used to determine study eligibility.
Your information is secure and will never be shared with third parties
11373 Cortez Blvd Building C, Suite 200
Brooksville, FL 34613
Monday-Friday: 9am-5pm
Free parking available
Wheelchair accessible